£140.00
The latest triple-pathway innovation, designed to maximise fat loss, increase satiety, and maintain lean muscle.
EXCIPIENTS
Water for injection, sodium chloride, trehalose, disodium phosphate dihydrate, methionine, M-Cresol, sodium hydroxide.
Retatrutide is a triple agonist that activates GLP-1, GIP, and glucagon receptors. By stimulating GLP-1 and GIP, it enhances insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite. Activation of the glucagon receptor increases fat burning and energy expenditure. This combined triple action improves blood sugar control and drives significant weight loss, offering greater metabolic benefits than single or dual agonists. Retatrutide is currently being studied for obesity and type 2 diabetes.
For Research Use Only
This product is supplied strictly for scientific research and laboratory experimentation. It is not intended for human consumption, clinical use, or any form of therapeutic application.
